Evolving Strategies in the Treatment of Anaemia in Chronic Kidney Disease: The HIF-Prolyl Hydroxylase Inhibitors
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical)
Link
https://link.springer.com/content/pdf/10.1007/s40265-022-01783-3.pdf
Reference180 articles.
1. Lamerato L, James G, van Haalen H, Hedman K, Sloan JA, Tang A, et al. Epidemiology and outcomes in patients with anemia of CKD not on dialysis from a large US healthcare system database: a retrospective observational study. BMC Nephrol. 2022;23:166.
2. Locatelli F, Pisoni RL, Combe C, Bommer J, Andreucci VE, Piera L, et al. Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2004;19(1):121–32.
3. Available at: https://www.who.int/health-topics/anaemia#tab=tab_1 Last viewed on the 17th of June, 2022
4. Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. N Engl J Med. 1987;316(2):73–8.
5. Winearls CG, Pippard MJ, Downing MR, Cotes PM. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet. 1986;ii:1175–7.
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Renoprotective Effects of Daprodustat in Patients with Chronic Kidney Disease and Renal Anemia;International Journal of Molecular Sciences;2024-08-30
2. Renal anemia: from relative insufficiency of EPO to imbalance of erythropoiesis and eryptosis;International Urology and Nephrology;2024-07-09
3. New Therapeutic Approaches to Management of Anemia and Iron Metabolism in Chronic Kidney Disease;Advances in Small Animal Care;2024-07
4. Can we effectively manage chronic kidney disease with a precision-based pharmacotherapy plan? Where are we?;Expert Opinion on Pharmacotherapy;2024-06-12
5. Association between roxadustat use and suppression of thyroid function: a systematic review and meta-analysis;Journal of Pharmaceutical Health Care and Sciences;2024-06-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3